Results 231 to 240 of about 388,981 (242)

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity

Pharmaceuticals, 2021
Racheal A Nell, Andrea Vasas, Judit Hohmann   +2 more
exaly  

Latency Reversal 2.0: Giving the Immune System a Seat at the Table

Current HIV/AIDS Reports, 2021
Ann Chahroudi, Maud Mavigner, Amir Dashti   +2 more
exaly  

HIV latency reversal agents: A potential path for functional cure?

European Journal of Medicinal Chemistry, 2021
Jean Leandro Dos Santos, Juliana Romano Lopes, Diego Eidy Chiba   +2 more
exaly  

Potentiation of Drug Toxicity through Virus Latency Reversal Promotes Preferential Elimination of HIV Infected Cells

Advanced Therapeutics, 2022
Alexander N. Zelikin, Lucy Kate Ladefoged, Camilla Kaas Frich   +2 more
exaly  

Orientation-reversal VEP: Comparison of phase and peak latencies in adults and infants

Vision Research, 2012
Oliver Braddick, Janette Atkinson, John Wattam-Bell   +2 more
exaly  

Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.

Journal of Virology, 2018
Mark M Painter, Kathleen L. Collins, Thomas D Zaikos   +2 more
exaly  

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.

Journal of Virology, 2018
Carolina Garrido, Guido Ferrari
exaly  

Novel Latency Reversal Agents for HIV-1 Cure

Annual Review of Medicine, 2018
Vicente Planelles, Adam M Spivak
exaly  

Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1

EBioMedicine, 2019
Robbie B. Mailliard, Tatiana M Garcia-Bates, Charles R Rinaldo   +2 more
exaly  

Pattern reversal evoked potentials: gender differences and age-related changes in amplitude and latency

Electroencephalography and Clinical Neurophysiology - Evoked Potentials, 1994
Donnell J Creel, Robert E Dustman, Donald E Shearer   +2 more
exaly